AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The DC Cohort Longitudinal HIV Status Neutral Study

Recruitingn/aAges any - anyAllGeorge Washington University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Treatment Cohort Inclusion Criteria: * Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort. * Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent. * Patient is a minor who is consented by a parent or legal guardian. Treatment Cohort Exclusion Criteria: * Patient is unable or refuses to provide informed consent. * Minor children ages 12 through 17 who are unaware of their HIV status Prevention Cohort Inclusion Criteria: Persons receiving any antiretroviral prescription without evidence of HIV or Hepatitis B infection * PrEP (e.g., TDF/FTC, Descovy, Apretude) * Combination ART indicative of nPEP in an HIV-uninfected person * Persons receiving an antiretroviral prescription indicative of DoxyPEP Doxycycline 200mg PO taken within 72 hrs of unprotected sexual encounter (or variations thereof where clearly not prescribed as a treatment course) * Test positive for โ‰ฅ1 bacterial STI (positive gonorrhea (GC/NG) or chlamydia (CT) test or positive syphilis test requiring treatment within one year) * 2 bacterial STI (GC, chlamydia, syphilis) tests at 2 or more different encounters * 2 HIV tests at 2 or more different encounters * Patient requesting PrEP at their clinical visit * Patient requesting nPEP at their clinical visit * People who identify as injecting drugs Patients with a Z29.81 Encounter for HIV pre-exposure prophylaxis
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

14 sites
Kaiser Permanente Mid-Atlantic States
Washington D.C., United States
Unity Health Care
Washington D.C., United States
Georgetown University
Washington D.C., United States
La Clinica Del Pueblo
Washington D.C., United States
Whitman-Walker Health
Washington D.C., United States
Children's National Medical Center--Pediatric Clinic
Washington D.C., United States
Washington Hospital Center
Washington D.C., United States
Washington Health Institute
Washington D.C., United States

โ€ฆand 6 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy